A low dose of streptozotocin prevents kainic acid-induced seizures and lethal effects in the rat

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 7, 1997, Pages 503-505

  Kim, Hyoung Chun ^a   Im, Doo Hyun ^a   Jhoo, Wang Kee ^a   Kim, Chin ^a   Wie, Myung Bok ^b  

^a Kangwon National University   (South Korea)

^b Samchundang Pharm Co Ltd   (South Korea)

Author keywords

Kainic acid; Neuroprotective effect; Nitric oxide; Streptozotocin

Indexed keywords

KAINIC ACID; NITRIC OXIDE; NITRIC OXIDE DONOR; PROTEIN C FOS; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; HIPPOCAMPUS; IMMUNOREACTIVITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; SEIZURE;

EID: 0030918179     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01235.x     Document Type: Article

References (13)

1. Choi DW. Nitric oxide: Foe or friend to the injured brain? Proc. Natl Acad. Sci. USA 1993; 90: 9741-3.
2. Kown NS, Lee SH, Choi CS, Kho T, Lee HS. Nitric oxide generation from streptozotocin. FASEB J. 1994; 8: 529-33.
3. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc. Natl Acad. Sci. USA 1991; 88: 6107-11.
4. Buisson A, Lakhmeche N, Verrecchia C, Plotkine M, Boulu RG. Nitric oxide: Endogenous anticonvulsant substance. Neuroreport 1993; 4: 444-6.
5. Bing G, McMillian M, Kim H et al. Long-term expression of the 35 000 mol wt. Fos-related antigen in rat brain after kainic acid treatment. Neuroscience 1996; 73: 1159-74.
6. Kim HC, Pennypacker K, Bing G, Bronstein D, McMillian MK, Hong JS. The effects of dextromethorphan on kainic acid-induced seizures in the rut. Neurotoxicology 1996; 17: 375-86.
7. Pennypacker KR, Thai L, Hong JS, McMillian MK. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J. Neurosci. 1994; 14: 3998-4006.
8. Herrera DG, Robertson HA. N-Methyl-D-aspartate receptors mediate activation of the c-fos proto-oncogene in a model of brain injury. Neuroscience 1990; 35: 273-81.
9. Fariello RG, Golden GT, Smith GG, Reyes PF. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by NMDA receptor antagonist. Epilepsy Res. 1989; 3: 206-13.
10. Lipton SA, Choi YB, Pan Z et al. A redox-based mechanism tor the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626-32.
11. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: The free radical, nitric oxide. Ann. Neurol. 1992; 32: 297-311.
12. Przegalinski E, Baran L, Siwanowicz J. The role of nitric oxide in the kainate-induced seizures in mice. Neurosci. Lett. 1994; 170: 74-6.
13. Maggio R, Fumagalli F, Donati E et al. Inhibition of nitric oxide synthase dramatically potentiates seizures induced by kainic acid and pilocarpine in rats. Brain Res. 1995; 679: 184-7.